My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 94

    1.

    CTLA-4 blockade during dendritic cell based booster vaccination influences dendritic cell survival and CTL expansion.

    Pedersen AE, Ronchese F.

    J Immune Based Ther Vaccines. 2007 Jul 29;5:9.PMID: 17662155 [PubMed]Related articlesFree article

    2.

    Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.

    Kim JH, Kang TH, Noh KH, Bae HC, Kim SH, Yoo YD, Seong SY, Kim TW.

    Immunol Lett. 2009 Jan 29;122(1):58-67. Epub 2009 Jan 9.PMID: 19135479 [PubMed - indexed for MEDLINE]Related articles

    3.

    Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cells in vitro.

    Cai YG, Fang DC, Chen L, Tang XD, Chen T, Yu ST, Luo YH, Xiong Z, Wang DX, Yang SM.

    Tumour Biol. 2007;28(4):238-46. Epub 2007 Aug 23.PMID: 17717429 [PubMed - indexed for MEDLINE]Related articles

    4.

    Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity.

    Shinozaki Y, Wang S, Miyazaki Y, Miyazaki K, Yamada H, Yoshikai Y, Hara H, Yoshida H.

    Int J Cancer. 2009 Mar 15;124(6):1372-8.PMID: 19089917 [PubMed - indexed for MEDLINE]Related articles

    5.

    Late dendritic cells are still able to evoke a potent alloreactive CTL response.

    Repnik U, Bergant M, Wraber B, Jeras M.

    Immunobiology. 2008;213(1):51-64. Epub 2007 Aug 6.PMID: 18207027 [PubMed - indexed for MEDLINE]Related articles

    6.

    In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.

    Koido S, Homma S, Hara E, Mitsunaga M, Namiki Y, Takahara A, Nagasaki E, Komita H, Sagawa Y, Ohkusa T, Fujise K, Gong J, Tajiri H.

    J Transl Med. 2008 Sep 15;6:51.PMID: 18793383 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Enhanced antitumor immunity elicited by dendritic cell vaccines is a result of their ability to engage both CTL and IFN gamma-producing NK cells.

    Karimi K, Boudreau JE, Fraser K, Liu H, Delanghe J, Gauldie J, Xing Z, Bramson JL, Wan Y.

    Mol Ther. 2008 Feb;16(2):411-8. Epub 2007 Dec 4.PMID: 18059374 [PubMed - indexed for MEDLINE]Related articles

    8.

    An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells.

    He XZ, Wang L, Zhang YY.

    World J Gastroenterol. 2008 Jan 28;14(4):532-40.PMID: 18203284 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.

    Trepiakas R, Pedersen AE, Met O, Hansen MH, Berntsen A, Svane IM.

    Vaccine. 2008 Jun 2;26(23):2824-32. Epub 2008 Apr 11.PMID: 18450338 [PubMed - indexed for MEDLINE]Related articles

    10.

    Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo.

    Wu YG, Wu GZ, Wang L, Zhang YY, Li Z, Li DC.

    Med Oncol. 2009 Aug 8. [Epub ahead of print]PMID: 19669608 [PubMed - as supplied by publisher]Related articles

    11.

    Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.

    Bonehill A, Van Nuffel AM, Corthals J, Tuyaerts S, Heirman C, François V, Colau D, van der Bruggen P, Neyns B, Thielemans K.

    Clin Cancer Res. 2009 May 15;15(10):3366-75. Epub 2009 May 5.PMID: 19417017 [PubMed - indexed for MEDLINE]Related articles

    12.

    Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice.

    Chen L, Tang XD, Yu ST, Ai ZH, Fang DC, Cai YG, Luo YH, Liang GP, Yang SM.

    J Pathol. 2009 Apr;217(5):685-92.PMID: 19142972 [PubMed - indexed for MEDLINE]Related articles

    13.

    Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naïve cytotoxic priming and anti-tumour therapy.

    Merrick A, Diaz RM, O'Donnell D, Selby P, Vile R, Melcher A.

    Cancer Immunol Immunother. 2008 Jun;57(6):897-906. Epub 2007 Dec 4.PMID: 18057935 [PubMed - indexed for MEDLINE]Related articles

    14.

    CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.

    Gonzalez-Carmona MA, Lukacs-Kornek V, Timmerman A, Shabani S, Kornek M, Vogt A, Yildiz Y, Sievers E, Schmidt-Wolf IG, Caselmann WH, Sauerbruch T, Schmitz V.

    Hepatology. 2008 Jul;48(1):157-68.PMID: 18537185 [PubMed - indexed for MEDLINE]Related articles

    15.

    Dendritic cell vaccines in melanoma: from promise to proof?

    Lesterhuis WJ, Aarntzen EH, De Vries IJ, Schuurhuis DH, Figdor CG, Adema GJ, Punt CJ.

    Crit Rev Oncol Hematol. 2008 May;66(2):118-34. Epub 2008 Feb 8. Review.PMID: 18262431 [PubMed - indexed for MEDLINE]Related articles

    16.

    In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.

    Wu A, Oh S, Gharagozlou S, Vedi RN, Ericson K, Low WC, Chen W, Ohlfest JR.

    J Immunother. 2007 Nov-Dec;30(8):789-97.PMID: 18049330 [PubMed - indexed for MEDLINE]Related articles

    17.

    Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination.

    Chambers B, Grufman P, Fredriksson V, Andersson K, Roseboom M, Laban S, Camps M, Wolpert EZ, Wiertz EJ, Offringa R, Ljunggren HG, van Hall T.

    Cancer Res. 2007 Sep 15;67(18):8450-5.PMID: 17875682 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo.

    Liu L, Chavan R, Feinberg MB.

    BMC Immunol. 2008 Apr 15;9:15.PMID: 18412969 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer.

    Matera L.

    Cancer Treat Rev. 2009 Nov 30. [Epub ahead of print]PMID: 19954892 [PubMed - as supplied by publisher]Related articles

    20.

    Increasing the survival of dendritic cells in vivo does not replace the requirement for CD4+ T cell help during primary CD8+ T cell responses.

    Matthews KE, Qin JS, Yang J, Hermans IF, Palmowski MJ, Cerundolo V, Ronchese F.

    J Immunol. 2007 Nov 1;179(9):5738-47.PMID: 17947646 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk